BB Biotech invests in fast-growing biotechnology companies that are developing and marketing innovative drugs. It focuses on biotech companies whose products address areas of significant unmet medical needs and thus have above-average sales and profit-growth potential.
The renowned Board of Directors of BB Biotech AG has many years of industrial and scientific experience. A team of proven biotech specialists from Bellevue Asset Management AG takes care of investments in the most attractive biotech companies.
Die BB Biotech AG verwendet Cookies, um die Funktionen der Website zu optimieren und Ihnen das bestmögliche Erlebnis zu gewährleisten.Gebrauch von Cookies & Disclaimer
